LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin

Cited by (586)

Items 101–200 of 586

1. Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
   Iris Z. Uras, Herwig Peter Moll, Emilio Casanova · 2020 · International Journal of Molecular Sciences
2. Cross-talk between protein synthesis, energy metabolism and autophagy in cancer
   Lisa Lindqvist, Kristofferson V. Tandoc, Ivan Topisirović, Luc Furic · 2017 · Current Opinion in Genetics & Development
3. Caloric restriction and cancer: molecular mechanisms and clinical implications
   Ophélie Meynet, Jean‐Ehrland Ricci · 2014 · Trends in Molecular Medicine
4. Phosphorylation of BRAF by AMPK Impairs BRAF-KSR1 Association and Cell Proliferation
   Che‐Hung Shen, Ping Yuan, Rolando Pérez‐Lorenzo, Yaqing Zhang, Sze Xian Lee, Yang Ou, John M. Asara, Lewis C. Cantley, Bin Zheng · 2013 · Molecular Cell
5. Variant classification in precision oncology
   Jonas Leichsenring, Peter Horak, Simon Kreutzfeldt, Christoph Heining, Petros Christopoulos, Anna‐Lena Volckmar, Olaf Neumann, Martina Kirchner, Carolin Ploeger, Jan Budczies et al. · 2019 · International Journal of Cancer
6. Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
   Matilda Lee, Jayshree L. Hirpara, Jie Qing Eu, Gautam Sethi, Lingzhi Wang, Boon-Cher Goh, Andrea L.A. Wong · 2018 · Redox Biology
7. An AMPK-Independent Signaling Pathway Downstream of the LKB1 Tumor Suppressor Controls Snail1 and Metastatic Potential
   Jonathan M. Goodwin, Robert U. Svensson, Hua Jane Lou, Monte M. Winslow, Benjamin E. Turk, Reuben J. Shaw · 2014 · Molecular Cell
8. KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing
   Tony Kiat Hon Lim, Ferdinandos Skoulidis, Keith M. Kerr, Myung‐Ju Ahn, Joshua R. Kapp, Fernando Augusto Soares, Yasushi Yatabe · 2023 · Lung Cancer
9. Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer
   Biplab Dasgupta, Rishi Raj Chhipa · 2015 · Trends in Pharmacological Sciences
10. Mitochondrial Complex I Activity Is Required for Maximal Autophagy
    Hala Elnakat Thomas, Yu Zhang, Jonathan A. Stefely, Sónia R. Veiga, George Thomas, Sara C. Kozma, Carol A. Mercer · 2018 · Cell Reports
11. Phenformin as an Anticancer Agent: Challenges and Prospects
    María Eugenia García Rubiño, Esmeralda Carrillo, Gloria Ruiz-Alcalá, Alicia Domínguez‐Martín, Juan Antonio Marchal, Houría Boulaiz · 2019 · International Journal of Molecular Sciences
12. Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches
    Katherine Klein, Kewen He, Ahmed I. A. Younes, Hampartsoum B. Barsoumian, Dawei Chen, Tugce Ozgen, Sara Mosaffa, Roshal R. Patel, Meidi Gu, Jose A. Monteiro de Oliveira Novaes et al. · 2020 · Frontiers in Immunology
13. Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment
    Michaël Pollak · 2014 · Nature Medicine
14. Autophagy modulates lipid metabolism to maintain metabolic flexibility for Lkb1 -deficient Kras -driven lung tumorigenesis
    Vrushank Dharmesh Bhatt, Khoosheh Khayati, Zhixian Sherrie Hu, Amy Shiu Lee, Wali Kamran, Xiaoyang Su, Jessie Yanxiang Guo · 2019 · Genes & Development
15. AMP-activated protein kinase: A target for old drugs against diabetes and cancer
    Gian Luigi Russo, Maria Russo, Paola Ungaro · 2013 · Biochemical Pharmacology
16. The double-edged sword of AMPK signaling in cancer and its therapeutic implications
    Sang‐Min Jeon, Nissim Hay · 2015 · Archives of Pharmacal Research
17. Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia
    Pierre Sujobert, Laury Poulain, Étienne Paubelle, Florence Zylbersztejn, Adrien Grenier, M. Lambert, Elizabeth C. Townsend, Jean-Marie G. Brusq, Edwige Nicodème, Justine Decrooqc et al. · 2015 · Cell Reports
18. A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
    Timothy S. Pardee, Rebecca G. Anderson, Kristin M. Pladna, Scott P. Isom, Lais P. Ghiraldeli, Lance David Miller, Jeff W. Chou, Guangxu Jin, Wei Zhang, Leslie Renee Ellis et al. · 2018 · Clinical Cancer Research
19. Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma
    Müge Çeliktaş, Ichidai Tanaka, S. C. Tripathi, Johannes Francois Fahrmann, Clemente Aguilar-Bonavides, Pamela Andrea Villalobos, Oliver Delgado, Dilsher S. Dhillon, Jennifer B. Dennison, Edwin Justin Ostrin et al. · 2016 · JNCI Journal of the National Cancer Institute
20. Skp2-Dependent Ubiquitination and Activation of LKB1 Is Essential for Cancer Cell Survival under Energy Stress
    Szu-Wei Lee, Chien‐Feng Li, Guoxiang Jin, Zhen Cai, Fei Han, Chia‐Hsin Chan, Wei‐Lei Yang, Binkui Li, Abdol Hossein Rezaeian, Hongyu Li et al. · 2015 · Molecular Cell
21. Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy
    Alba Luengo, Lucas B. Sullivan, Matthew G. Vander Heiden · 2014 · BMC Biology
22. STK11/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact
    Elvire Pons Tostivint, Alexandre Lugat, Jean-François Fontenau, Marc Guillaume Denis, Jaafar Bennouna · 2021 · Cells
23. Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism
    Maria João Meneses, Branca Maria Silva, Mário Sousa, Rosália Sá, Pedro Fontes Oliveira, Marco Gouveia Alves · 2015 · Current Pharmaceutical Design
24. Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC
    Massimo Moro, Elisa Caiola, Monica Ganzinelli, Elisabetta Zulato, Eliana Rulli, Mirko Marabese, Giovanni Centonze, Adele Busico, Ugo Pastorino, Filippo de Braud et al. · 2018 · Journal of Thoracic Oncology
25. Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials
    Suzanne Eleanor Dahlberg, Joan H. Schiller, Philip Bonomi, Alan B. Sandler, Julie Renee Brahmer, Suresh S. Ramalingam, David H. Johnson · 2013 · Journal of Thoracic Oncology
26. AMPK and Cancer
    Zhiyu Wang, Neng Wang, Pengxi Liu, Xiaoming Xie · 2016 · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions
27. Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy
    Marianne Koritzinsky · 2015 · International Journal of Radiation Oncology*Biology*Physics
28. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery
    Zhipeng Chen, Liujie Zhang, Yang Song, Jiayu He, Li Wu, Can Zhao, Yanyu Xiao, Wei Li, Baochang Cai, Haibo Cheng et al. · 2015 · Biomaterials
29. Molecular Pathways: BRAF Induces Bioenergetic Adaptation by Attenuating Oxidative Phosphorylation
    Rizwan Haq, David E. Fisher, Hans R. Widlund · 2014 · Clinical Cancer Research
30. Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
    Mariacarmela Santarpía, Andrés Aguilar, Imane CHAIB-OUKADOUR, Andrés Felipe Cardona, Sara Fancelli, Fernando Laguía, Jillian Wilhelmina Paulina Bracht, Peng Cao, Miguel Ángel Molina‐Vila, Niki Karachaliou et al. · 2020 · Cancers
31. The Anti-Proliferative Effect of Metformin in Triple-Negative MDA-MB-231 Breast Cancer Cells Is Highly Dependent on Glucose Concentration: Implications for Cancer Therapy and Prevention
    Zordoky, Beshay N.M., Bark, Diana, Soltys, Carrie L., Sung, Miranda M., Dyck, Jason R.B. · 2014 · Biochimica et Biophysica Acta (BBA) - General Subjects
32. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma
    Wei Jiang, Susan Finniss, Simona Cazacu, Cunli Xiang, Ziv Brodie, Tom Mikkelsen, Laila Poisson, David B. Shackelford, Chaya Brodie · 2016 · Oncotarget
33. Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung Cancer
    Rui Li, Ramin Salehi‐Rad, William P. Crosson, Milica Momcilovic, Raymond J. Lim, Stephanie L. Ong, Zi Ling Huang, Tian-hao Zhang, Jensen W. Abascal, Camelia Dumitras et al. · 2021 · Cancer Research
34. Targeting LKB1 in Cancer – Exposing and Exploiting Vulnerabilities
    Momcilovic, M, Shackelford, D B · 2015 · British Journal of Cancer
35. Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres
    Junseong Park, Jin‐Kyoung Shim, Joon Hee Kang, Junjeong Choi, Jong Hee Chang, Soo‐Youl Kim, Seok‐Gu Kang · 2017 · Neuro-Oncology
36. Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity
    Ian P. Winters, Shin‐Heng Chiou, Nicole K. Paulk, Christopher D. McFarland, Pranav V. Lalgudi, Rosanna K. Ma, Leszek Lisowski, Andrew J. Connolly, Dmitri A. Petrov, Mark A. Kay et al. · 2017 · Nature Communications
37. YAP Promotes Malignant Progression of Lkb1 -Deficient Lung Adenocarcinoma through Downstream Regulation of Survivin
    Wenjing Zhang, Yijun Gao, Fuming Li, Xinyuan Tong, Yan Ren, Xiangkun Han, Shun Yao, Fei Long, Zhongzhou Yang, Heng‐Yu Fan et al. · 2015 · Cancer Research
38. Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment
    Xinbing Sui, Yinghua Xu, Xian Wang, Weidong Han, Hongming Pan, Mang Xiao · 2015 · Molecular Pharmaceutics
39. LKB1 Loss Induces Characteristic Patterns of Gene Expression in Human Tumors Associated with NRF2 Activation and Attenuation of PI3K-AKT
    Kaufman, Jacob M., Amann, Joseph M., Park, Kyungho, Arasada, Rajeswara Rao, Li, Haotian, Shyr, Yu, Carbone, David P. · 2014 · Journal of Thoracic Oncology
40. Metformin: current clinical applications in nondiabetic patients with cancer
    Kailin Chen, Yajun Li, Zhen Guo, Yong Zeng, Wei Zhang, Hui Wang · 2020 · Aging
41. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases
    Yanghe Zhang, Qingfei Meng, Qianhui Sun, Zhixiang Xu, Honglan Zhou, Yishu Wang · 2020 · Molecular Metabolism
42. Dissecting the role of AMP-activated protein kinase in human diseases
    Jin Li, Liping Zhong, Fengzhong Wang, Haibo Zhu · 2017 · Acta Pharmaceutica Sinica B
43. Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation
    Shenghong Yang, Yu Imamura, Russell William Jenkins, Israel Cañadas, Shunsuke Kitajima, Amir Reza Aref, Arthur Brannon, Eiji Oki, Adam B. Castoreno, Zehua Zhu et al. · 2016 · Cancer Immunology Research
44. Evidence of cancer‐promoting roles for AMPK and related kinases
    Tiziana Monteverde, Nathiya Muthalagu, Jennifer Port, Daniel J. Murphy · 2015 · FEBS Journal
45. A reappraisal on metformin
    Tuğba Adak, Afshin Samadi, Ayşe Zeynep Ünal, Suna Sabuncuoğlu · 2017 · Regulatory Toxicology and Pharmacology
46. Different prognostic impact ofSTK11mutations in non-squamous non-small-cell lung cancer
    Nicolas Pécuchet, Pierre Laurent‐Puig, Audrey Mansuet‐Lupo, Antoine Legras, Marco Alifano, Karine Pallier, Audrey Didelot, Laure Gibault, Claire J. Danel, Pierre‐Alexandre Just et al. · 2015 · Oncotarget
47. Metabolic reprogramming of carcinoma-associated fibroblasts and its impact on metabolic heterogeneity of tumors
    Duojiao Wu, Leying Zhuo, Xiangdong Wang · 2016 · Seminars in Cell and Developmental Biology
48. Inflammation as a driver and vulnerability of KRAS mediated oncogenesis
    Shunsuke Kitajima, Rohit Thummalapalli, David Allen Barbie · 2016 · Seminars in Cell and Developmental Biology
49. Oncogene-Driven Metabolic Alterations in Cancer
    Hye‐Young Min, Ho‐Young Lee · 2017 · Biomolecules & Therapeutics
50. Syrosingopine sensitizes cancer cells to killing by metformin
    Don Benjamin, Marco Colombi, Sravanth Kumar Hindupur, Charles Betz, Heidi A. Lane, Mahmoud El‐Shemerly, Min Lu, Luca Quagliata, Luigi Terracciano, Suzette Moes et al. · 2016 · Science Advances
51. Hernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancers
    Betty Yuen Kwan Law, Simon Wing Fai Mok, Wai Kit Chan, Su Xu, Anguo Wu, Xiao Yao, Jing Rong Wang, Liang Liu, Vincent Kam Wai Wong · 2016 · Oncotarget
52. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis
    Qi Li, Fang Liu, Feng Zhang, Shuai Zhang, Liyan Lv, Yi Bi, Yan Yu · 2018 · Biomedicine & Pharmacotherapy
53. CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis
    Lucy Penfold, Angela Woods, Phillip J. Muckett, Alexander Yu. Nikitin, Tera R. Kent, Shuai Zhang, Rebecca Graham, Alice Pollard, David Carling · 2018 · Cancer Research
54. Pyruvate kinase M knockdown–induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival
    Gopinath Prakasam, Rajnish Kumar Singh, Mohammad Askandar Iqbal, Sunil Kumar Saini, Ashu Bhan Tiku, Ramesh N K Bamezai · 2017 · Journal of Biological Chemistry
55. Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase
    Hannah R. Bridges, Ville A. Sirviö, Ahmed-Noor Adam Agip, Judy Hirst · 2016 · BMC Biology
56. Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
    Ji‐Hye Park, Young‐Heon Kim, Eun Hyeh Park, Sun‐Joo Lee, Hye Won Kim, Areumnuri Kim, Seung Bum Lee, Sehwan Shim, Hyosun Jang, Jae Kyung Myung et al. · 2019 · Cancer Science
57. The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing
    Valentina Tesori, Anna Chiara Piscaglia, Daniela Samengo, Marta Barba, Camilla Bernardini, Roberto Scatena, Alessandro Pontoglio, Laura Castellini, Johannes N. Spelbrink, Giuseppe Maulucci et al. · 2015 · Scientific Reports
58. Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
    Floris H. Groenendijk, Wouter Willem Mellema, Eline van der Burg, Eva Schut, Michael Hauptmann, Hugo M. Horlings, Stefan M. Willems, Michel M. van den Heuvel, Jos Jonkers, Egbert Frederik Smit et al. · 2014 · International Journal of Cancer
59. HDAC3 is critical in tumor development and therapeutic resistance in Kras -mutant non–small cell lung cancer
    Lillian J. Eichner, Stephanie D. Curtis, Sonja N. Brun, Caroline K. McGuire, Irena Gushterova, Joshua T. Baumgart, Elijah Trefts, Debbie S. Ross, Tammy J. Rymoff, Reuben J. Shaw · 2023 · Science Advances
60. lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1
    Xiaowen Liu, Boyi Gan · 2016 · Cell Cycle
61. Controlling the master—upstream regulation of the tumor suppressor LKB1
    Kullmann, Lars, Krahn, Michael P. · 2018 · Oncogene
62. Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer
    Ray Pillai, Sarah E. LeBoeuf, Yuan Hao, Connie New, Jenna L. E. Blum, Ali Rashidfarrokhi, Shih Ming Huang, Christian Bahamon, Warren Wu, Burcu Karadal-Ferrena et al. · 2024 · Science Advances
63. A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?
    Kunal Maniar, Amal Moideen, Ankur Mittal, Amol Patil, Amitava Chakrabarti, Dibyajyoti Banerjee · 2016 · Pharmacological Research
64. The LKB1-AMPK Pathway—Friend or Foe in Cancer?
    David Grahame Hardie · 2013 · Cancer Cell
65. Metabolic rewiring in mutant Kras lung cancer
    Emma M. Kerr, Carla P. Martins · 2017 · FEBS Journal
66. Dihydroartemisinin Inhibits Glucose Uptake and Cooperates with Glycolysis Inhibitor to Induce Apoptosis in Non-Small Cell Lung Carcinoma Cells
    Yanjun Mi, Guojun Geng, Zhengzhi Zou, Jing Gao, Xianyang Luo, Yu Liu, Ning Li, Chunlei Li, Yuqiang Chen, Xiuyi Yu et al. · 2015 · PLoS ONE
67. Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer
    Alba Luengo, Keene L. Abbott, Shawn M. Davidson, Aaron M. Hosios, Brandon Faubert, Sze Ham Chan, Elizaveta Freinkman, Lauren G. Zacharias, Thomas P. Mathews, Clary B. Clish et al. · 2019 · Nature Communications
68. Recent Progress on Liver Kinase B1 (LKB1): Expression, Regulation, Downstream Signaling and Cancer Suppressive Function
    Ren‐You Gan, Hua‐Bin Li · 2014 · International Journal of Molecular Sciences
69. Snail acetylation by autophagy‐derived acetyl‐coenzyme A promotes invasion and metastasis of KRAS ‐ LKB1 co‐mutated lung cancer cells
    Jang Hee Han, Yong Keon Kim, Hakhyun Kim, Jooyoung Lee, Myung Joon Oh, Minjee Kim, Kook Hwan Kim, Kook Hwan Kim, Hyun Ju Yoon, Myung‐Shik Lee et al. · 2022 · 癌症：英文版
70. LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism
    Qinghua Zeng, J Chen, Yong Li, Kaitlin D. Werle, R-X Zhao, C-S Quan, Y-S Wang, Y-X Zhai, Wang Jw, Mariam Youssef et al. · 2016 · Oncogene
71. A Highly Sensitive FRET Biosensor for AMPK Exhibits Heterogeneous AMPK Responses among Cells and Organs
    Yumi Konagaya, Kenta Terai, Yusuke Hirao, Kanako Takakura, Masamichi Imajo, Yuji Kamioka, Norio Sasaoka, Akira Kakizuka, Kenta Sumiyama, Tomoichiro Asano et al. · 2017 · Cell Reports
72. Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation
    Diana Vara‐Ciruelos, Madhumita Dandapani, Fiona M. Russell, Katarzyna M. Grzes, Abdelmadjid Atrih, Marc Foretz, Benoı̂t Viollet, Douglas J. Lamont, Doreen Ann Cantrell, David Grahame Hardie · 2019 · Cell Reports
73. The Mechanism of Action of Biguanides: New Answers to a Complex Question
    Laura Di Magno, Fiorella Di Pastena, Rosa Bordone, Sonia Coni, Gianluca Canettieri · 2022 · Cancers
74. FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth
    Xiaona Zhu, Ping He, Liang Zhang, Shuo Yang, Huilin Zhang, Di Zhu, Meng-Di Liu, Yun Yu · 2019 · Cell Death and Disease
75. Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions
    Anna Luisa Di Stefano, Alberto Pïcca, Édouard Saragoussi, Franck Bielle, François Ducray, Chiara Villa, Marica Eoli, Rosina Paterra, Luisa Bellu, Bertrand Mathon et al. · 2020 · Neuro-Oncology
76. Therapeutic Repurposing of Biguanides in Cancer
    Hongyun Zhao, Kenneth D. Swanson, Bin Zheng · 2021 · Trends in cancer
77. Mitochondrial mutations and metabolic adaptation in pancreatic cancer
    Australian Pancreatic Cancer Genome Initiative, Rae‐Anne Hardie, Ellen van Dam, Mark J. Cowley, Ting­-Li Han, Seher Balaban, Marina Pajic, Mark Pinese, Mary Iconomou, Robert F. Shearer et al. · 2017 · Cancer & Metabolism
78. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status
    Sara Granja, Ibtissam Marchiq, Renaud LeFloch, Conceição Souto Moura, Fátima Baltazar, Jacques Pouysségur · 2014 · Oncotarget
79. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells
    Yong Won Choi, In Kyoung Lim · 2014 · Cancer Letters
80. Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
    Ke Xu, Dongkyoo Park, Andrew T. Magis, Jun Zhang, Wei Zhou, Gabriel Sica, Suresh S. Ramalingam, Walter John Curran, Xingming Deng · 2019 · Molecular Cancer
81. Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism
    Yunxia Liu, Jinyan Feng, Mingming Sun, Bowen Liu, Guang Yang, Yanan Bu, Man Zhao, Tianjiao Wang, Weiying Zhang, Hong-Feng Yuan et al. · 2018 · Acta Pharmacologica Sinica
82. MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity
    María José Sandí, Christopher B. Marshall, Marc Balan, Étienne Coyaud, Ming Zhou, Daniel M. Monson, Noboru Ishiyama, Arun A. Chandrakumar, José La Rose, Amber L. Couzens et al. · 2017 · Science Signaling
83. Targeting cellular metabolism to reduce head and neck cancer growth
    Jian Yang, Yuqi Guo, Wonkyu Seo, Ruohan Zhang, Cuijie Lu, Yaoyu E. Wang, Liang Luo, Bidisha Paul, Wenbo Yan, Deepak B. Saxena et al. · 2019 · Scientific Reports
84. KRAS/LKB1 and KRAS/TP53 co-mutations create divergent immune signatures in lung adenocarcinomas
    Meichen Gu, Tiankai Xu, Pengyu Chang · 2021 · Therapeutic Advances in Medical Oncology
85. LKB1 reduces ROS-mediated cell damage via activation of p38
    H-G Xu, Y-X Zhai, Jianfeng Chen, Yan Lu, J-W Wang, C-S Quan, R-X Zhao, Xiao Xiao, Qiongqiong He, Kaitlin D. Werle et al. · 2014 · Oncogene
86. Targeting the LKB1 Tumor Suppressor
    Rui–Xun Zhao, Zhi‐Xiang Xu · 2014 · Current Drug Targets
87. LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells
    Young Mi Whang, Serk In Park, Irina A. Trenary, Robert A. Egnatchik, Joshua P. Fessel, Jennifer Kaufman, David Paul Carbone, Jamey D. Young · 2015 · Oncogene
88. Mechanisms of metformin inhibiting cancer invasion and migration.
    Yong Chang Chen, He Li, Jing Wang · 2020 · PubMed Central
89. The Metabolic Heterogeneity and Flexibility of Cancer Stem Cells
    Atsushi Tanabe, Hiroeki Sahara · 2020 · Cancers
90. Energy metabolism in cancer stem cells
    Xuan Zhu, Huihui Chen, Chenyi Gao, Xinxin Zhang, Jingxin Jiang, Yi Zhang, Jun Fang, Feng Zhao, Zhigang Chen · 2020 · World Journal of Stem Cells
91. AMP-Activated Protein Kinase: Do We Need Activators or Inhibitors to Treat or Prevent Cancer?
    Fiona M. Russell, David Grahame Hardie · 2020 · International Journal of Molecular Sciences
92. Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma
    Melissa Gilbert‐Ross, Jessica Marie Konen, Junghui Koo, John A. Shupe, Brian Scott Robinson, Walter Guy Wiles, Chunzi Huang, W. David Martin, Madhusmita Behera, Geoffrey Hughes Smith et al. · 2017 · JCI Insight
93. Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer
    Yongliang Wang, Ali R. Nasiri, William Damsky, Curtis J. Perry, Xian‐Man Zhang, Aviva Rabin-Court, Michaël Pollak, Gerald I. Shulman, Rachel J. Perry · 2018 · Cell Reports
94. Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial
    Anish B. Parikh, Peter S. Kozuch, Nicholas Cole Rohs, Daniel Jacob Becker, Benjamin Philip Levy · 2017 · Investigational New Drugs
95. A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses
    Carlos A. Arbelaez, Juan Estrada, Melissa A. Gessner, Charles Glaus, Agnieszka B. Morales, Deanna Mohn, Hyewon Phee, James Russell Lipford, James A. Johnston · 2020 · npj Vaccines
96. Metformin, an Old Drug, Brings a New Era to Cancer Therapy
    Huan He, Rong Ke, Hui Lin, Ying Ying, Dan Liu, Zhijun Luo · 2015 · The Cancer Journal
97. Multispectral Imaging
    James Robert Mansfield · 2013 · Veterinary Pathology
98. LKB1 promotes metabolic flexibility in response to energy stress
    Seth J. Parker, Robert U. Svensson, Ajit S. Divakaruni, Austin E.Y.T. Lefebvre, Anne N. Murphy, Reuben J. Shaw, Christian M. Metallo · 2016 · Metabolic Engineering
99. Noncanonical agonist PPARγ ligands modulate the response to DNA damage and sensitize cancer cells to cytotoxic chemotherapy
    Melin Janardan Khandekar, Alexander S. Banks, Dina Laznik-Bogoslavski, James P. White, Jang Hyun Choi, Lawrence Kazak, James C. Lo, Paul Cohen, Kwok‐Kin Wong, Theodore M. Kamenecka et al. · 2018 · Proceedings of the National Academy of Sciences
100. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing
     Yong Wu, Marianna Sarkissyan, Eva M. McGhee, Sangkyu Lee, Jaydutt V. Vadgama · 2015 · Breast Cancer Research and Treatment